Bolton Medical announced it has completed enrolment of its ADVANCE European clinical study to evaluate the safety and efficacy of the Treovance abdominal stent-graft with Navitel delivery system for use in endovascular aortic repair (EVAR) of abdominal aortic aneurysms.
Physicians at five hospitals across Europe have enrolled 30 patients. The final case was performed by Vicente Riambau at Hospital Clinic of Barcelona, Spain.
“The Bolton ADVANCE study has been completed and so far the device shows promising results”, said Roberto Chiesa, principal investigator. “I think that the Treovance abdominal sten-graft continues a new generation of devices focused on providing: low-profile systems, precise deployment, stent-graft repositioning and additionally offers features to minimise late disconnections.”
Treovance features accurate deployment, flexible design, multiple fixation points and wide range of sizes. The low profile Navitel delivery system is equipped with a detachable sheath and allows for controlled or rapid deployment of the Treovance abdominal stent-graft.
